NOTCH2 and liver cancer: It is possible that these findings hold true in the context of liver cancer, as NOTCH2 is amplified in 10% of HCC patients (28); however, again, further studies are needed to demonstrate a role for tumor-intrinsic Notch signaling in promoting immune escape in the context of liver cancer.